# Supernus Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 30, 2026

- Company: [Supernus Pharmaceuticals, Inc.](/companies/supn.md) (CIK 1356576)
- Form: DEF 14A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 17:00 ET
- Period: 2026-06-18
- Accession: 0001104659-26-053111
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-053111. Last ingested by Listed: Nov 4, 2026, 18:21 ET. No prices; not investment advice.